$BMRN BIOMARIN PHARMACEUTICAL INC Insider Trading Week 12/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC in week 12/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | A | 87.42 | 36,280 | 3,171,598 | 36,820 | |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 0.00 | 11,220 | 0 | 84,949 | 73.7 K to 84.9 K (+15.22 %) |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 87.42 | 144,050 | 12,592,851 | 144,050 | |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 44,520 | 0 | 235,194 | 190.7 K to 235.2 K (+23.35 %) |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Option Exercise | A | 87.42 | 7,740 | 676,631 | 7,740 | |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Grant | A | 0.00 | 4,790 | 0 | 18,080 | 13.3 K to 18.1 K (+36.04 %) |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | A | 87.42 | 64,030 | 5,597,503 | 64,030 | |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Grant | A | 0.00 | 19,790 | 0 | 140,192 | 120.4 K to 140.2 K (+16.44 %) |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Option Exercise | A | 87.42 | 39,480 | 3,451,342 | 39,480 | |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Grant | A | 0.00 | 12,200 | 0 | 55,422 | 43.2 K to 55.4 K (+28.23 %) |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Option Exercise | A | 87.42 | 39,480 | 3,451,342 | 39,480 | |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 0.00 | 12,200 | 0 | 26,671 | 14.5 K to 26.7 K (+84.31 %) |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Option Exercise | A | 87.42 | 38,420 | 3,358,676 | 38,420 | |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 0.00 | 11,870 | 0 | 147,491 | 135.6 K to 147.5 K (+8.75 %) |